Reuters logo
BRIEF-Quidel receives FDA clearance for its point-of-care Sofia® Lyme FIA
October 23, 2017 / 1:13 PM / in 2 months

BRIEF-Quidel receives FDA clearance for its point-of-care Sofia® Lyme FIA

Oct 23 (Reuters) - Quidel Corp

* Quidel receives FDA clearance for its point-of-care Sofia® Lyme FIA

* Quidel - ‍Sofia Lyme FIA is for detecting human antibodies to Borrelia burgdorferi from serum & plasma specimens from patients with B. burgdorferi infection​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below